Page last updated: 2024-10-27

fluorouracil and Angiomyxoma

fluorouracil has been researched along with Angiomyxoma in 2 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lancaster, LD1
Ewy, GA1
Tuchmann, A1
Kerstan, E1
Euler-Rolle, J1

Reviews

1 review available for fluorouracil and Angiomyxoma

ArticleYear
Cardiac consequences of malignancy and their treatment.
    Advances in internal medicine, 1984, Volume: 30

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cyclophosphamide; Fluorouracil; Heart; Heart Neo

1984

Other Studies

1 other study available for fluorouracil and Angiomyxoma

ArticleYear
[Pseudomyxoma of the peritoneum (author's transl)].
    Leber, Magen, Darm, 1978, Volume: 8, Issue:2

    Topics: Ascites; Cystadenoma; Female; Fluorouracil; Humans; Hydrazines; Methotrexate; Middle Aged; Myxoma; O

1978